1,584 Shares in Cardinal Health, Inc. $CAH Bought by Simon Quick Advisors LLC

Simon Quick Advisors LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAHFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,584 shares of the company’s stock, valued at approximately $266,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Strs Ohio lifted its stake in Cardinal Health by 10.7% in the second quarter. Strs Ohio now owns 21,308 shares of the company’s stock worth $3,580,000 after acquiring an additional 2,058 shares during the period. Impact Partnership Wealth LLC purchased a new stake in Cardinal Health in the second quarter worth $656,000. Amalgamated Bank lifted its position in Cardinal Health by 3.6% during the second quarter. Amalgamated Bank now owns 55,271 shares of the company’s stock valued at $9,286,000 after buying an additional 1,933 shares during the period. Atria Investments Inc lifted its position in Cardinal Health by 10.9% during the second quarter. Atria Investments Inc now owns 23,636 shares of the company’s stock valued at $3,971,000 after buying an additional 2,326 shares during the period. Finally, Assetmark Inc. lifted its position in Cardinal Health by 2.6% during the second quarter. Assetmark Inc. now owns 79,417 shares of the company’s stock valued at $13,342,000 after buying an additional 1,989 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last three months. 0.12% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CAH shares. UBS Group raised their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday. Wells Fargo & Company reissued an “overweight” rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Citigroup raised their price objective on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research report on Friday. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Argus set a $189.00 price objective on Cardinal Health in a research report on Friday, August 22nd. Eleven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $200.54.

Check Out Our Latest Analysis on CAH

Cardinal Health Price Performance

CAH opened at $190.22 on Tuesday. The stock has a 50-day moving average price of $156.05 and a 200-day moving average price of $155.04. The firm has a market cap of $45.19 billion, a PE ratio of 29.49, a P/E/G ratio of 1.39 and a beta of 0.71. Cardinal Health, Inc. has a 1 year low of $110.63 and a 1 year high of $197.67.

Cardinal Health (NYSE:CAHGet Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.1%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.